Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed)
ID: 357254Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/357254

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-25-217.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a grant opportunity titled "Information and Practice Needs Relevant to Late Talking Children," aimed at enhancing understanding of the needs of caregivers and professionals supporting late-talking children. This initiative seeks to explore the information and practice requirements of stakeholders involved with children who do not meet expressive language milestones by 18 months, emphasizing community engagement and qualitative research to address existing knowledge gaps. The program encourages diverse research teams and mandates the submission of a Community Engagement Plan (CEP) and a Plan for Enhancing Diverse Perspectives (PEDP) to ensure inclusivity in research efforts. Funding is capped at $275,000 over a two-year period, with applications due by October 2, 2025. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-217.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-25-217-Full-Announcement.html
    PAR-25-217.html
    The National Institutes of Health (NIH) is offering funding through the "Information and Practice Needs Relevant to Late Talking Children" opportunity, emphasizing community engagement and qualitative research to address gaps in knowledge surrounding late talking in children. The initiative aims to explore the information and practice needs of caregivers, professionals, and other stakeholders supporting late-talking children—typically diagnosed when expressive language milestones are not met after 18 months. The program requires applicants to submit a Community Engagement Plan (CEP) and a Plan for Enhancing Diverse Perspectives (PEDP) to ensure inclusivity. Funding is capped at $275,000 over a two-year period and may vary based on the number of awarded projects. Eligible applicants include a variety of educational and governmental institutions, emphasizing diversity in research teams and stakeholder involvement. The grant's primary focus is on understanding the dissemination of information and best practices to improve outcomes for late-talking children, aiming for a significant influence on the field through rigorous, community-oriented research methodologies.
    Similar Opportunities
    Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children," aimed at advancing research on language development in children diagnosed with late talking after 18 months. This initiative encourages applicants to utilize existing datasets to identify patterns, predictors, and underlying factors related to late talking and its developmental outcomes, while promoting data sharing and secondary analysis. The total funding available is up to $275,000 over a two-year period, with a submission deadline of January 3, 2025. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-25-220.html.
    Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)" aimed at enhancing research in children's language development. This initiative encourages the creation of novel, culturally sensitive measurement tools to assess language abilities, particularly for children from diverse backgrounds, and emphasizes community-engaged research that incorporates input from affected communities. The program is part of the NIH TALK Initiative and seeks to broaden the understanding of environmental influences on language development, with funding available up to $275,000 for a two-year project period. Applications are due starting January 16, 2025, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancement and Innovation in Measurement of Language Development and Predictors," aimed at fostering community-engaged research that enhances the understanding of children's language development through culturally and linguistically responsive measures. Applicants are required to develop a Plan for Enhancing Diverse Perspectives (PEDP) and a Community Engagement (CE) plan, focusing on innovative tool development for assessing language capabilities across diverse populations and communicative contexts. The total funding available for projects is capped at $275,000 over a two-year period, with applications due by September 7, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-244.html.
    Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancement and Innovation in Measurement of Language Development and Predictors," aimed at fostering community-engaged research to enhance the understanding of language development in children. Applicants are required to submit a Community Engagement (CE) Plan and a Plan for Enhancing Diverse Perspectives (PEDP), which will be evaluated for scientific merit, with a focus on developing culturally and linguistically relevant assessment tools for diverse populations, particularly those from lower socioeconomic backgrounds. This grant, categorized under Income Security and Social Services, does not require cost-sharing and is open to a wide range of eligible applicants, including various educational institutions and community organizations. Interested parties should note that the application deadline is September 7, 2027, and can direct inquiries to grantsinfo@nih.gov for further information.
    Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)" aimed at enhancing research on children's language development. This initiative encourages community-engaged research to identify novel environmental factors that support language skills in children, emphasizing the development of strengths-focused and culturally responsive measures. The NIH seeks to broaden the understanding of language development and impairment, aligning with its commitment to reducing health disparities and ensuring inclusivity in research. Interested applicants must submit proposals that include a Community Engagement Plan and a Plan for Enhancing Diverse Perspectives, with submission deadlines starting January 5, 2025. For further details, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-112.html.
    NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity for low-risk clinical trials in communication disorders under Funding Opportunity Number PAR-24-051. This initiative aims to support investigator-initiated projects that develop effective interventions in areas such as hearing, speech, and language, specifically targeting low-risk clinical trials that do not require FDA oversight and adhere to budget limits of under $500,000 in direct costs per year. The funding is particularly significant for enhancing research in communication disorders, ultimately improving public health outcomes through scientifically validated interventions. Interested applicants can submit proposals starting January 5, 2024, with the opportunity closing on January 8, 2028; for further inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), is offering research grants aimed at translating basic research findings into clinical practice, specifically for communication disorders. This funding opportunity encourages collaborations between basic scientists and clinicians to develop practical applications that address hearing, balance, smell, taste, voice, and language disorders, with a focus on milestone-driven proposals that demonstrate a clear connection to clinical conditions and impactful outcomes. The grants, limited to a maximum of $500,000 in direct costs annually, are expected to support 2-3 awards in FY25, with applications due by October 12, 2027. Interested applicants can find more information and submit their proposals through Grants.gov, and may contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)" aimed at advancing precision medicine for pregnant individuals, lactating persons, and children. This grant seeks to support innovative research that develops novel tools and technologies, enhances understanding of drug mechanisms, and improves therapeutic options for these populations, particularly those with disabilities. The initiative is part of the R21 Exploratory/Developmental Research Grants program, with a funding cap of $275,000 over a potential two-year period, and requires a Data Management and Sharing Plan as part of the application process. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov, with the application deadline set for May 7, 2026.
    Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)" aimed at expanding knowledge of disorders that are currently or may become part of statewide newborn screening programs. This initiative seeks to gather comprehensive data on the natural history of these conditions to facilitate appropriate interventions for affected infants, improve diagnostic accuracy, and support the development of targeted treatments. The funding will assist in identifying biological mechanisms, understanding genetic diversity, and establishing data collection systems for longitudinal studies, emphasizing the importance of research in newborn screening. Interested applicants, including various educational and community organizations, can submit proposals with a maximum project period of five years, with the funding cycle opening on January 5, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-227.html.
    Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)" aimed at promoting research and development of novel screening methods and therapeutic interventions for conditions identified through newborn screening. This initiative encourages innovative projects that generate preliminary data on both existing and potentially fatal genetic disorders, emphasizing the importance of early detection and intervention. The program is open to a wide range of eligible applicants, including higher education institutions, nonprofits, and governmental bodies, with a total funding ceiling of $275,000 over two years. Interested applicants should note that the submission deadlines begin on January 16, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.